Michael Masetti

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Vascular Endothelial Growth Factor

Ejection Fraction

Top Venues

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer (2024)
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer 154 (12) (2024)
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer 154 (12) (2024)